New Ideas.
Better Results.

Blue Matter is a consulting firm serving the life sciences industry. We strive to bring a new approach to consulting with original ideas that deliver a meaningful impact.

Contact Us

Our Purpose

We are proud to be part of an industry that is pushing the boundaries of science and technology to improve people’s lives. Our role is to help our clients identify unique insights, generate new ideas and drive meaningful results to get the most out of their products, portfolios and teams.

We began our careers in established consulting firms where we developed valuable experience and industry knowledge. During this time, we came to see that rigid processes often interfered with original thinking and led to bloated deliverables packed with mediocre answers.

A group of us like-minded, passionate consultants believed there was a better approach and founded Blue Matter to provide a platform to foster innovation and creativity in consulting.

Our Difference

Industry and scientific knowledge, analysis and insights. Left brain thinking. This is the foundation of our discipline. Creativity and imagination. Constantly challenging conventional thinking and seeking fresh ideas. Right brain thinking. We’re passionate about this; it’s the reason our clients come back.

The key to winning is effective differentiation. And effective differentiation comes from originality–thinking that is grounded in reason and infused with imagination.

"The terrific work you did resulted in a substantial change to our commercial strategy."

- Chairman of the Board, Small Biotech

"Thank you very much for the great work and partnership. You are one of the rare breed of consultants whom I trust. You will always be on my speed dial if we need help with anything."

- Chief Commercial Officer, Small Biotech

"I appreciate all of the great work you have done for our team this past year and look forward to continued partnership in the New Year."

- Chief Commercial Officer, Mid-sized Diagnostic Company

"Your preparation and support has been instrumental in achieving our desired outcome."

- Franchise Commercial Lead, Global Biotech

"Thank you all so much for the extremely successful project...I couldn't be happier with the way that it went."

- Sr. Product Manager, Diagnostic Company

"This project was excellent, from the content development to facilitation. Many, many thanks for the great work!"

- Director of Marketing, Diagnostic Company

"The process was great, I loved that I didn't have to manage you that much. Everything was highly organized and done on time. Quality and originality of thinking was also good."

- Global Commercial Lead, Large Biotech

"Great project. I was learning as we went along; good expertise — brought in examples from other projects."

- Global Commercial Lead, Large Biotech

Our Clients

Our clients include: top global bio-pharmaceutical companies with large, diverse product portfolios to small emerging players with one asset in development, leading diagnostic companies, and investment houses. We work with CEOs, Chief Commercial Officers, Franchise Heads, Product Directors, Functional Area Leaders. 90%+ of our business is from repeat, satisfied customers.

Our Services

We maximize value at the product, portfolio and organization levels.

Product

Shape innovative products and maximize value throughout the lifecycle

Portfolio

Optimize portfolio and therapeutic area investments

Organization

Design and build great organizations

Market Access Capabilities

In-depth market access expertise, coupled with extensive experience in strategy development

PathfinderSM

An integrated suite of capabilities to help biopharma companies enter European markets and succeed

Therapeutic Expertise

Broad therapeutic expertise with an in-depth focus on complex and specialty markets

Want to Join Our Team?

Blue Matter offers enriching project experiences with a diverse range of strategic, client-facing projects in the exciting and innovative life sciences industry.

Join Our Team

Insights

NEW #WhitePaper - #MedicalAffairs is becoming a key leader in holistic "molecule level" strategy development. This… https://t.co/msQnBQWFfP

NEW - The final installment in our series, 12 Pitfalls in #Europe. Our team discusses the dangers of poor planning… https://t.co/Zu6JqNYwsM

12 Pitfalls in Europe: Pitfall #12 – Caring too late about your infrastructure

At some point in its development, any growth-minded non-European biopharma company will look to Europe as a possible source of new opportunity.  Europe is attractive for various reasons, including its large population, high per-capita spend on healthcare, and vast market potential. But successfully entering Europe is a complex undertaking, and biopharma companies need to know … Read More

Medical Affairs Metamorphosis, Part IV: Medical Affairs as a Strategic Leader

Throughout this series, we’ve been discussing how the roles and expectations for the Medical Affairs function are evolving.  Various trends are driving this evolution, raising Medical Affairs’ profile within the biopharma enterprise.  Medical Affairs is becoming a central hub for generating insights that can inform strategic planning.  It’s also becoming a nexus for generating evidence … Read More

12 Pitfalls in Europe: Pitfall #11 – Using Individual Preferences vs. Analysis to Select HQ Location

At some point in its development, any growth-minded non-European biopharma company will look to Europe as a possible source of new opportunity.  Europe is attractive for various reasons, including its large population, high per-capita spend on healthcare, and vast market potential. But successfully entering Europe is a complex undertaking, and biopharma companies need to know … Read More

12 Pitfalls in Europe: Pitfall #10 – Building Like Big Pharma When You’re Not

At some point in its development, any growth-minded non-European biopharma company will look to Europe as a possible source of new opportunity.  Europe is attractive for various reasons, including its large population, high per-capita spend on healthcare, and vast market potential. But successfully entering Europe is a complex undertaking, and biopharma companies need to know … Read More

Medical Affairs Metamorphosis, Part III: How Medical Affairs is Becoming a Key Hub for Evidence Generation

When a biopharma company develops a new therapy, it’s not satisfied with simply getting market authorization in key geographies. Rather, a company wants to ensure broad, sustainable access and safe, confident use by healthcare providers (HCPs) that supports improved patient outcomes. To achieve these goals, it must consider the needs of a complex healthcare ecosystem … Read More

COVID-19’s Impact on the Mental and Behavioral Health Landscape: Two-Year Blip or Permanent Change?

There’s no doubt that the COVID-19 pandemic brought major disruption to people across the globe.  Of course, it affected people’s health. But it also caused major shake-ups in people’s finances, as well as the ways in which they work, socialize, worship, and more –  impacting all facets of personal and public life. Interestingly, it also … Read More

12 Pitfalls in Europe: Pitfall #9 – Missing a Promotable Label

At some point in its development, any growth-minded non-European biopharma company will look to Europe as a possible source of new opportunity.  Europe is attractive for various reasons, including its large population, high per-capita spend on healthcare, and vast market potential. But successfully entering Europe is a complex undertaking, and biopharma companies need to know … Read More

Companies

The Blue Matter family also includes other leading companies that provide specialized support to the biopharmaceutical industry.

Blue Matter companies often work together to help clients achieve their goals.

Learning & development programs & consulting focused on the life sciences

www.saliencelearning.com

Life science supply chain design, management, & consulting

www.aimconnection.eu